We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Factors Likely to Affect Procter & Gamble's (PG) Q3 Earnings
Read MoreHide Full Article
The Procter & Gamble Company (PG - Free Report) is set to report third-quarter fiscal 2022 results on Apr 20, before the opening bell. The company is expected to deliver sales and earnings growth in the to-be-reported quarter.
The Zacks Consensus Estimate for the company’s fiscal third-quarter earnings is pegged at $1.29 per share, indicating 2.4% growth from the year-ago quarter’s reported figure. The consensus mark has moved down by a penny in the past 30 days. For fiscal third-quarter revenues, the consensus mark is pegged at $18.7 billion, suggesting 3.1% growth from the prior-year quarter’s reported figure.
In the last reported quarter, the company delivered an earnings surprise of 0.6%. Its bottom line beat estimates by 3.3%, on average, over the trailing four quarters.
Procter & Gamble Company The Price and EPS Surprise
Procter & Gamble has been gaining from improved productivity and persistent demand for cleaning products. The company’s third-quarter fiscal 2022 results are expected to reflect the benefits of continued strength in brands and appropriate strategies, which have been aiding organic sales growth. Notably, the Zacks Consensus Estimate for organic sales growth is pegged at 6%, which suggests an improvement from 4% reported in the prior-year quarter.
The company has been focused on productivity and cost-saving plans, which have been aiding its margins. PG has been witnessing cost savings and efficiency improvements across all facets of its business, driven by the productivity program. Its continued business investments and efforts to offset macro cost headwinds, and balanced top and bottom-line growth underscore its productivity efforts. Gains from productivity savings and pricing are expected to have aided margins and the bottom line in the fiscal third quarter.
However, it has been reeling under commodity cost inflation, higher transportation costs, and increased investments in products and packaging. These have been weighing on PG’s gross margin despite gains from productivity savings.
On the last reported quarter’s earnings call, Procter & Gamble predicted higher commodity and freight costs to persist throughout fiscal 2022. Also, it has been witnessing rising input costs. This is anticipated to have weighed on the fiscal third-quarter performance.
Zacks Model
Our proven model does not conclusively predict an earnings beat for Procter & Gamble this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. However, this is not the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Procter & Gamble has a Zacks Rank #4 (Sell) and an Earnings ESP of -1.10%.
Stocks With Favorable Combination
Here are some companies you may want to consider, as our model shows that these have the right combination of elements to deliver an earnings beat.
Archer Daniels Midland (ADM - Free Report) currently has an Earnings ESP of +2.07% and a Zacks Rank of 2. The company is expected to register top-line growth when it reports first-quarter 2022 numbers. The Zacks Consensus Estimate for ADM’s quarterly revenues is pegged at $19.5 billion, which suggests growth of 3.2% from the prior-year quarter’s reported figure. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Archer Daniel’s quarterly earnings has moved up 2.2% in the past 30 days to $1.37 per share, suggesting a 1.4% decline from the year-ago reported number. ADM has delivered an earnings beat of 21.9%, on average, in the trailing four quarters.
TreeHouse Foods (THS - Free Report) presently has an Earnings ESP of +3.20% and a Zacks Rank #3. THS is likely to register top-line growth when it reports first-quarter 2022 numbers. The Zacks Consensus Estimate for its quarterly revenues is pegged at $1.1 billion, which suggests growth of 2.6% from the figure reported in the prior-year quarter.
However, the Zacks Consensus Estimate for TreeHouse’s quarterly bottom line has been unchanged in the past 30 days at a loss of 55 cents per share, suggesting a decline of 252.8% from the year-ago quarter’s reported number. THS has delivered an earnings beat of 11.9%, on average, in the trailing four quarters.
Corteva (CTVA - Free Report) currently has an Earnings ESP of +0.70% and a Zacks Rank #3. CTVA is anticipated to register top and bottom-line growth when it reports first-quarter 2022 results. The Zacks Consensus Estimate for Corteva’s quarterly revenues is pegged at $4.53 billion, indicating an improvement of 8.5% from the figure reported in the prior-year quarter.
The Zacks Consensus Estimate for Corteva’s bottom line has been unchanged in the past 30 days to 81 cents per share. However, the consensus estimate for CTVA suggests growth of 2.5% from the year-ago quarter’s reported figure.
Image: Bigstock
Factors Likely to Affect Procter & Gamble's (PG) Q3 Earnings
The Procter & Gamble Company (PG - Free Report) is set to report third-quarter fiscal 2022 results on Apr 20, before the opening bell. The company is expected to deliver sales and earnings growth in the to-be-reported quarter.
The Zacks Consensus Estimate for the company’s fiscal third-quarter earnings is pegged at $1.29 per share, indicating 2.4% growth from the year-ago quarter’s reported figure. The consensus mark has moved down by a penny in the past 30 days. For fiscal third-quarter revenues, the consensus mark is pegged at $18.7 billion, suggesting 3.1% growth from the prior-year quarter’s reported figure.
In the last reported quarter, the company delivered an earnings surprise of 0.6%. Its bottom line beat estimates by 3.3%, on average, over the trailing four quarters.
Procter & Gamble Company The Price and EPS Surprise
Procter & Gamble Company The price-eps-surprise | Procter & Gamble Company The Quote
Key Factors to Note
Procter & Gamble has been gaining from improved productivity and persistent demand for cleaning products. The company’s third-quarter fiscal 2022 results are expected to reflect the benefits of continued strength in brands and appropriate strategies, which have been aiding organic sales growth. Notably, the Zacks Consensus Estimate for organic sales growth is pegged at 6%, which suggests an improvement from 4% reported in the prior-year quarter.
The company has been focused on productivity and cost-saving plans, which have been aiding its margins. PG has been witnessing cost savings and efficiency improvements across all facets of its business, driven by the productivity program. Its continued business investments and efforts to offset macro cost headwinds, and balanced top and bottom-line growth underscore its productivity efforts. Gains from productivity savings and pricing are expected to have aided margins and the bottom line in the fiscal third quarter.
However, it has been reeling under commodity cost inflation, higher transportation costs, and increased investments in products and packaging. These have been weighing on PG’s gross margin despite gains from productivity savings.
On the last reported quarter’s earnings call, Procter & Gamble predicted higher commodity and freight costs to persist throughout fiscal 2022. Also, it has been witnessing rising input costs. This is anticipated to have weighed on the fiscal third-quarter performance.
Zacks Model
Our proven model does not conclusively predict an earnings beat for Procter & Gamble this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the chances of an earnings beat. However, this is not the case here. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Procter & Gamble has a Zacks Rank #4 (Sell) and an Earnings ESP of -1.10%.
Stocks With Favorable Combination
Here are some companies you may want to consider, as our model shows that these have the right combination of elements to deliver an earnings beat.
Archer Daniels Midland (ADM - Free Report) currently has an Earnings ESP of +2.07% and a Zacks Rank of 2. The company is expected to register top-line growth when it reports first-quarter 2022 numbers. The Zacks Consensus Estimate for ADM’s quarterly revenues is pegged at $19.5 billion, which suggests growth of 3.2% from the prior-year quarter’s reported figure. You can see the complete list of today’s Zacks #1 Rank stocks here.
The Zacks Consensus Estimate for Archer Daniel’s quarterly earnings has moved up 2.2% in the past 30 days to $1.37 per share, suggesting a 1.4% decline from the year-ago reported number. ADM has delivered an earnings beat of 21.9%, on average, in the trailing four quarters.
TreeHouse Foods (THS - Free Report) presently has an Earnings ESP of +3.20% and a Zacks Rank #3. THS is likely to register top-line growth when it reports first-quarter 2022 numbers. The Zacks Consensus Estimate for its quarterly revenues is pegged at $1.1 billion, which suggests growth of 2.6% from the figure reported in the prior-year quarter.
However, the Zacks Consensus Estimate for TreeHouse’s quarterly bottom line has been unchanged in the past 30 days at a loss of 55 cents per share, suggesting a decline of 252.8% from the year-ago quarter’s reported number. THS has delivered an earnings beat of 11.9%, on average, in the trailing four quarters.
Corteva (CTVA - Free Report) currently has an Earnings ESP of +0.70% and a Zacks Rank #3. CTVA is anticipated to register top and bottom-line growth when it reports first-quarter 2022 results. The Zacks Consensus Estimate for Corteva’s quarterly revenues is pegged at $4.53 billion, indicating an improvement of 8.5% from the figure reported in the prior-year quarter.
The Zacks Consensus Estimate for Corteva’s bottom line has been unchanged in the past 30 days to 81 cents per share. However, the consensus estimate for CTVA suggests growth of 2.5% from the year-ago quarter’s reported figure.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.